Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 340,084,384
  • Shares Outstanding, K 2,682,900
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.74
  • Price/Sales 4.43
  • Price/Cash Flow 13.20
  • Price/Book 5.64

Price Performance

See More
Period Period Low Period High Performance
1-Month
123.54 +3.62%
on 04/02/18
132.88 -3.66%
on 04/16/18
+0.62 (+0.49%)
since 03/26/18
3-Month
122.15 +4.80%
on 02/05/18
144.94 -11.68%
on 01/29/18
-17.32 (-11.92%)
since 01/26/18
52-Week
122.15 +4.80%
on 02/05/18
148.32 -13.69%
on 01/17/18
+4.50 (+3.64%)
since 04/26/17

Most Recent Stories

More News
7 striking facts about the money tech companies are making

Everyone knows the tech industry is rich, but it can be challenging to get your head around just how much money it's minting.

AAPL : 164.22 (+0.35%)
JNJ : 128.01 (+0.99%)
XOM : 80.86 (+1.71%)
Look for Shares of Johnson&Johnson to Potentially Pullback after Yesterday's 1.35% Rise

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $126.62 to a high of $128.52. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of...

JNJ : 128.01 (+0.99%)
AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains

AbbVie's (ABBV) Q1 earnings top estimates with revenues marginally beating the same. Sales of the company's lead marketed drug, Humira, also rise year over year.

LGND : 158.62 (+2.52%)
JNJ : 128.01 (+0.99%)
INFI : 2.26 (+4.63%)
ABBV : 97.44 (+6.06%)
Johnson & Johnson Announces Dividend Increase of 7.1%

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 7.1% increase in the quarterly dividend rate, from $0.84 per share to $0.90 per share. The increase was announced...

JNJ : 128.01 (+0.99%)
Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses

Bristol-Myers (BMY) beats estimates on both counts in the first quarter. Eliquis and Opdivo record solid sales.

JNJ : 128.01 (+0.99%)
PFE : 36.85 (+0.46%)
BMY : 52.04 (+0.54%)
NKTR : 84.19 (+1.94%)
V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced...

JNJ : 128.01 (+0.99%)
Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?

Style Box ETF report for PFM

MSFT : 94.26 (+2.11%)
PFM : 25.41 (+0.67%)
JNJ : 128.01 (+0.99%)
IWD : 121.42 (+0.41%)
XOM : 80.86 (+1.71%)
VTV : 104.60 (+0.49%)
Global Vision Care Market 2018-2022: Key Vendors are Essilor, Johnson & Johnson, Novartis, The Cooper Companies, Valeant Pharmaceuticals & ZEISS

The "Global Vision Care Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

JNJ : 128.01 (+0.99%)
NVS : 77.21 (+1.03%)
Love, Gilda Director/Producer Lisa D'Apolito Announced As Keynote Speaker Of Gilda's Club NYC 11th Celebrating Women Luncheon, May 9

Gilda's Club NYC will host its 11th Annual Celebrating Women luncheon, at the Metropolitan Club on Wednesday, May 9th. Lisa D'Apolito, director/producer of acclaimed documentary, Love, Gilda will present...

JNJ : 128.01 (+0.99%)
MKKGY : 20.0400 (+1.08%)
Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX

Four pharma/biotech companies are set to release earnings report on Apr 26. Let's take a look into how the companies are placed ahead of the upcoming results.

JNJ : 128.01 (+0.99%)
VRTX : 158.81 (+2.36%)
NVS : 77.21 (+1.03%)
ABBV : 97.44 (+6.06%)
BMY : 52.04 (+0.54%)
ALXN : 121.42 (+14.50%)
BIIB : 273.86 (+1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 130.55
1st Resistance Point 129.28
Last Price 128.01
1st Support Level 126.68
2nd Support Level 125.35

See More

52-Week High 148.32
Fibonacci 61.8% 138.32
Fibonacci 50% 135.24
Fibonacci 38.2% 132.15
Last Price 128.01
52-Week Low 122.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar